<DOC>
	<DOCNO>NCT02849184</DOCNO>
	<brief_summary>The purpose study compare effectiveness safety suvorexant versus placebo sleep pressure circadian rhythm hypertensive insomnia .</brief_summary>
	<brief_title>To Compare Effectiveness Suvorexant v Placebo Sleep Pressure Hypertensives With Insomnia</brief_title>
	<detailed_description>The study consist 4-week run-in period 2-week treatment period .</detailed_description>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Suvorexant</mesh_term>
	<criteria>[ At interim registration ] Patients meet follow criterion eligible study : 1 . Patients give write consent agreement voluntarily participation clinical study 2 . Age 20 year old 3 . Sex : Male female 4 . Treatment classification : Outpatient 5 . Hypertensive patient meet least one follow : Under antihypertensive medication Clinic systolic blood pressure ( SBP ) less 160 mmHg 6 . Patients insomnia meet least one following : Patients one follow symptom twice week least 1 monthcontinuation : difficulty initiate sleep ( time sleep onset 2 hour longer usual ) , difficulty maintain sleep ( awaken twice night ) , early morning awakening ( awaken 2 hour earlier morning usual ) , difficulty sleep deeply ( soundly asleep feeling time awaken morning ) . b . Patients interference social occupational function due insomnia symptom [ At official registration ] Patients meet follow criterion end runin period eligible study : 1 . Stable unchanged antihypertensive medication runin period . 2 . Average morning home SBP 135 mmHg 5 day end runin period . 1 . Patients serious liver disease . 2 . Patients serious respiratory disease . 3 . Patients secondary hypertension 4 . Patients sleep apnea syndrome 5 . Patients history narcolepsy cataplexy 6 . Patients history organic cerebral disorder 7 . Patients history hypersensitivity suvorexant 8 . Patients receive CYP3A stronglyinhibitors include itraconazole , clarithromycin ritonavir , saquinavir , nelfinavir , indinavir , telaprevir voriconazole start runin period 9 . Patients average clinic SBP 160 mmHg start runin period 10 . Patients receive suvorexant hypnotic start runin period regular basis 11 . Patients breastfeed , pregnant , possibly pregnant , plan become pregnant 12 . Patients consider eligible study investigator subinvestigator</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>